2026 American Association for Cancer Research
Review scientific findings and information presented by Dana-Farber physician-scientists at the 2026 AACR Annual Meeting in San Diego, CA, April 17-22, 2026.
2026 AACR Renal Cell Carcinoma Highlights
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the renal cell carcinoma clinical updates you need to know from AACR 2026.
Medical Oncology
2026 AACR Bladder Cancer Highlights
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from AACR 2026.
Medical Oncology
2026 AACR Prostate Cancer Highlights
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from AACR 2026.
Medical Oncology
AACR 2026 Recap
- The STAT Recap, sponsored by Dana-Farber
News Releases
- Dana-Farber Researchers to Present More Than 50 Research Studies at American Association for Cancer Research Annual Meeting 2026
- Dana-Farber Phase 1 Study Explores Toxicity Reduction in Combination of Trastuzumab Deruxtecan and Olaparib in Advanced HER2-Expressing Malignancies
- Dana-Farber Phase 2 Trial Shows Deep and Lasting Responses to CAR T-Cell Therapy for High-Risk Smoldering Multiple Myeloma
Resources
Follow us on social media
- X (formerly Twitter)
- @DanaFarber Cancer Institute - Information on our expert cancer care and advanced research
- @DanaFarberNews - Your source for Dana-Farber news
- @DFBC_PedCare - Dana-Farber/Boston Children's Cancer and Blood Disorders Center
- Bluesky